Jacobus Pharmaceutical Recalls Ruzurgi Tablets Due to Potential Contamination of Yeast, Mold, and Aerobic Bacteria

Jacobus Pharmaceutical Company recalled three lots of Ruzurgi (amifampridine) 10-mg tablets due to potential health risk. Laboratory tests found that the product is contaminated with yeast, mold, and aerobic bacteria that may cause serious and life-threatening infections. The use of …

Read more

Johnson & Johnson Seeks FDA Clearance for Booster Doses

Johnson & Johnson on Tuesday petitioned the Food and Drug Administration to approve a booster shot of its single-dose COVID-19 vaccine for people 18 years and older. J&J’s application indicatded that a late-stage study shows that a booster dose given …

Read more

BioNTech CEO Says Updated COVID-19 Vaccines May Be Needed in 2022

The head of BioNTech, the German company behind the first COVID-19 vaccine, said that the world will likely need new vaccines next year to protect against mutations of the virus. Ugur Sahin, CEO of BioNTech, told the Financial Times that …

Read more

Indonesia Negotiating with WHO to Become Global Vaccine Hub

Indonesian Health Minister said Indonesia is negotiating with the World Health Organization (WHO) and six drug companies to become a global vaccine hub.  “We are working with the WHO to be one of the global manufacturing hubs for mRNA,” Health …

Read more

Everest Medicines Purchases Canadian mRNA Vaccine Rights in $670 Million Deal

Chinese biopharmaceutical firm Everest Medicines has inked two definitive agreements to license an mRNA COVID-19 vaccine from Canada’s Providence Therapeutics Holdings, the two companies announced on Monday. The move reflects the pharmaceutical firms’ aim to bring a very effective inoculation …

Read more